SMAD3 and neoplasm: The reduced expression levels of TGF-β1 and p-Smad3 proteins further confirmed that siTGF-β1@ILP effectively inhibited tumor cell proliferation and migration by suppressing the TGF-β/Smad signaling pathway, thereby exerting significant antitumor effects.